Fact Sheet

Financial Aid for Macular Degeneration Medications

Learn about financial aid resources that may be available to help cover the costs of your macular degeneration prescription medications.

Macular Degeneration Medications

(On mobile devices, swipe left to see all of the table columns.)

The following table lists the phone numbers of pharmaceurtical companies to call to inquire about potential glaucoma medication financial assistance.

Medication NameGenericDrug CompanyToll-Free Number
Macugen®Pegaptanib SodiumBausch and Lomb1-833-862-8727
Visudyne®VerteporfinBausch and Lomb1-833-862-8727


Financial Aid Helpful Resources

(On mobile devices, swipe left to see all of the table columns.)

The following table lists organizations and phone numbers that provide financial aid for prescription medications.

OrganizationProgramPhone Number
Partnership for Prescription AssistancePrescription Assistance Service1-888-477-2669
RxHopePatient Assistance ProgramsNo toll-free number listed
Pan FoundationPatient Assistance Programs1-866-316-7263
NeedyMedsPatient Assistance Programs1-800-503-6897
MedicarePrescription Drug Plans1-800-633-4227



This content was first posted on: July 5, 2015

The information provided is a public service of the BrightFocus Foundation and is not intended to constitute medical advice. It should not in any way substitute for the advice of a qualified healthcare professional. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.

More Like This

  • Fact Sheet

    Macular Degeneration: Frequently Asked Questions

    Age-related macular degeneration (AMD) is a common eye disease that causes deterioration of the macula, the central area of the retina. Read the answers to the most frequently asked questions about this eye disease.

    March 1, 2016
  • Fact Sheet

    Clinical Trial Information for Macular Degeneration

    It can take many years for a potential treatment for macular degeneration to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    April 15, 2016
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Keep me informed about: *
Please select at least one.
You must select at least one disease category.
Please enter your first name.
Please enter your last name.